Betacoronavirus (drug effects) And NotGiacinto Abele Miggiano

List of bibliographic references

Number of relevant bibliographic references: 7.

Ident.	Authors (with country if any)	Title
000014	H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine]	[Potential antiviral therapeutics for 2019 Novel Coronavirus].
000092	Robert L. Kruse [États-Unis]	Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China.
000094	Guangdi Li ; Erik De Clercq	Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
000194	Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine]	Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
000255	G. Kampf [Allemagne] ; D. Todt [Allemagne] ; S. Pfaender [Allemagne] ; E. Steinmann [Allemagne]	Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
000428	Manisha Prajapat ; Phulen Sarma ; Nishant Shekhar ; Pramod Avti ; Shweta Sinha ; Hardeep Kaur ; Subodh Kumar ; Anusuya Bhattacharyya ; Harish Kumar ; Seema Bansal ; Bikash Medhi	Drug targets for corona virus: A systematic review
000430	Shibo Jiang	Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021